Dishman Carbogen Amcis Stock Drops -7.0% in Line with Industry Performance on November 13
On November 13, 2024, Dishman Carbogen Amcis, a smallcap pharmaceutical company, experienced a -7.0% decline in its stock price, in line with the underperformance of the pharmaceuticals and drugs industry. According to MarketsMojo, the company has been given a 'Strong Sell' rating based on recent performance and market trends. The stock is currently trading below its moving averages and has underperformed the market and Sensex, indicating potential challenges for the company.
Dishman Carbogen Amcis, a smallcap pharmaceutical company, saw a decline of -7.0% in its stock price on November 13, 2024. This drop was in line with the overall performance of the pharmaceuticals and drugs industry, which underperformed the market by -5.18% on the same day.
According to MarketsMOJO, a leading stock analysis platform, Dishman Carbogen Amcis has been given a 'Strong Sell' rating. This is based on the company's recent performance and market trends.
On November 13, the stock reached an intraday low of Rs 177.25, a decrease of -7.44% from the previous day's closing price. The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a downward trend.
In comparison to the overall market performance, Dishman Carbogen Amcis has underperformed the Sensex by -6.74% in the past day and -2.88% in the past month. This suggests that the company's stock has been affected by market conditions and trends.
As a smallcap company in the pharmaceutical industry, Dishman Carbogen Amcis may face challenges in the current market. However, the company's performance and stock price should be closely monitored by investors for any potential changes.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
